Nevro (NYSE: NVRO) reported Q2 EPS of ($0.69), in-line with the analyst estimate of ($0.69). Revenue for the quarter came in at $108.8 million versus the consensus estimate of $108.2 million.

Guidance:

Provides Third Quarter 2023 Revenue Guidance of $95 Million to $97 Million; Updates Full-Year 2023 Revenue Guidance to $410 Million to $415 Million, or 1% to 2% Constant Currency Growth Over 2022
Provides Third Quarter 2023 Non-GAAP Adjusted EBITDA Guidance of Negative $8 Million to Negative $10 Million; Updates Full-Year 2023 Non-GAAP Adjusted EBITDA Guidance to Negative $25 Million to Negative $28 Million

For earnings history and earnings-related data on Nevro (NVRO) click here.